Roivant Sciences Director Melissa Epperly Disposes Shares for Tax Withholding
Roivant Sciences Ltd.
Subscribe to track ROIV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📊 Form 4 Filing Analysis: Roivant Sciences Ltd. ($ROIV)
Insider: Melissa B. Epperly (Director) Transaction Date: September 10, 2026 Type: Tax Withholding (Code F) Shares Transacted: 2,179 Common Shares @ $40.94 Total Value: $89,208.26 Shares Held Post-Transaction: 14,838
Significance: Low (Routine net settlement to cover tax obligations upon vesting)
Comprehensive Analysis
Executive Summary
On September 14, 2026, Roivant Sciences Ltd. ($ROIV) filed a Form 4 on behalf of Director Melissa B. Epperly. The filing reports the disposition of 2,179 common shares on September 10, 2026, at a price of $40.94 per share, totaling $89,208.26.
Transaction Breakdown
- Transaction Code F: The disposition was executed via a net settlement to satisfy applicable tax withholding obligations tied to the vesting of common shares under the Non-Employee Director Compensation Plan.
- Post-Transaction Holdings: Following this transaction, Ms. Epperly directly retains 14,838 common shares of Roivant Sciences Ltd.
Market & Trading Impact
- Significance Assessment: Low.
- This was not an open-market sale or a discretionary transaction. Because Code F transactions are automatic withholding mechanisms to cover statutory taxes on equity award vestings, they do not reflect a change in insider sentiment regarding the company's operational performance or valuation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.